Suppr超能文献

[俄罗斯西北部地区的多发性硬化症:HLA分型结果]

[Multiple sclerosis in Northern-West region of Russia: results of HLA-typing].

作者信息

Odinak M M, Bisaga G N, Kalinina N M, Akimov S B, Semilutskaia I B

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(2):40-4.

Abstract

Distribution of antigens of A, B, DR loci of HLA system in standard lymphocytotoxic test was studied in 59 patients with a significant diagnosis of multiple sclerosis (MS) and in 138 healthy donors. In the patients elevated frequency of the next antigens was found as compared with the controls: A10 (37%; chi 2 = 6.31; p < 0.05; relative risk--RR = 2.34), B7 (37%; chi 2 = 4.62; p < 0.05; RR = 2.05), B13 (29%; chi 2 = 10.86; p < 0.01; RR = 3.59), B35 (17%; chi 2 = 4.27; p < 0.05; RR = 2.61), DR2 (68%; chi 2 = 11.61; p < 0.001; RR = 2.99), as well as DR6 (5%; chi 2 = 3.95; p < 0.05; RR = 7.34) and also DRw52 (24%; chi 2 = 27.49; p < 0.001; RR = 21.16). The highest value of etiologic fraction was found for DR2 antigen. Analysis of intralocus and extralocus combinations of antigens in MS revealed that significantly elevated frequency had only one combination--B7DR2 (25.4%; chi 2 = 9.77; p < 0.01; RR = 3.58), relative risk was higher for this combination than for each individual antigen separately: B7 (RR = 2.05), DR2 (RR = 2.99). Significant negative associations with a possible protective effect of separate alleles were established in MS for antigens HLA A2 (34%; chi 2 = 5.55; p < 0.05; RR = 0.47), A11 (7%; chi 2 = 4.66; p < 0.05; RR = 0.31), A30 (0%; chi 2 = 4.50, p < 0.05; RR = 0.01), B18 (8%; chi 2 = 4.55; p < 0.05; RR = 0.35), DR5 (59%; chi 2 = 10.17; p < 0.01; RR = 0.36). The most significant was a decrease of the frequency of DR5 antigen (p < 0.01). Patients with the recurrent course had prevailed antigens A11, B21, B35 and decreased frequencies of antigens A9, B13, DR7. However, only the difference in the frequency of DR7 (16% in remitting and 57% in progredient course, chi 2 = 10.02; p < 0.001; RR = 0.14) was significant.

摘要

在标准淋巴细胞毒性试验中,研究了59例确诊为多发性硬化症(MS)的患者及138名健康供者中HLA系统A、B、DR位点抗原的分布情况。与对照组相比,患者中以下抗原的频率升高:A10(37%;卡方=6.31;p<0.05;相对风险-RR=2.34)、B7(37%;卡方=4.62;p<0.05;RR=2.05)、B13(29%;卡方=10.86;p<0.01;RR=3.59)、B35(17%;卡方=4.27;p<0.05;RR=2.61)、DR2(68%;卡方=11.61;p<0.001;RR=2.99),以及DR6(5%;卡方=3.95;p<0.05;RR=7.34)和DRw52(24%;卡方=27.49;p<0.001;RR=21.16)。发现DR2抗原的病因分数最高。对MS患者抗原的基因座内和基因座外组合分析显示,频率显著升高的只有一种组合-B7DR2(25.4%;卡方=9.77;p<0.01;RR=3.58),该组合的相对风险高于单独的每个抗原:B7(RR=2.05),DR2(RR=2.99)。在MS患者中,发现某些单独等位基因具有可能的保护作用的显著负相关,这些抗原包括HLA A2(34%;卡方=5.55;p<0.05;RR=0.47)、A11(7%;卡方=4.66;p<0.05;RR=0.31)、A30(0%;卡方=4.50,p<0.05;RR=0.01)、B18(8%;卡方=4.55;p<0.05;RR=0.35)、DR5(59%;卡方=10.17;p<0.01;RR=0.36)。DR5抗原频率的降低最为显著(p<0.01)。复发型患者中A11、B21、B35抗原占优势,A9、B13、DR7抗原频率降低。然而,只有DR7频率的差异具有显著性(缓解期为16%,进展期为57%,卡方=10.02;p<0.001;RR=0.14)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验